Allosteric modulation of metabotropic glutamate receptors: Structural insights and therapeutic potential

This publication has 212 references indexed in Scilit:

• Activation of type 5 metabotropic glutamate receptors attenuates deficits in cognitive flexibility induced by NMDA receptor blockade
  European Journal of Pharmacology, 2010
• Dose-dependent effect of CDPPB, the mGluR5 positive allosteric modulator, on recognition memory is associated with GluR1 and CREB phosphorylation in the prefrontal cortex and hippocampus
  Neuropharmacology, 2009
• Discovery and Characterization of Novel Subtype-Selective Allosteric Agonists for the Investigation of M₁ Receptor Function in the Central Nervous System
  ACS Chemical Neuroscience, 2009
• Positive Allosteric Modulation of mGluR5 Receptors Facilitates Extinction of a Cocaine Contextual Memory
  Biological Psychiatry, 2009
• Activation of metabotropic glutamate receptors as a novel approach for the treatment of schizophrenia
  Trends in Pharmacological Sciences, 2009
• Correction of Fragile X Syndrome in Mice
  Neuron, 2007
• Positive Allosteric Modulation of Metabotropic Glutamate 5 (mGlu5) Receptors Reverses N-Methyl-D-Aspartate Antagonist-Induced Alteration of Neuronal Firing in Prefrontal Cortex
  Biological Psychiatry, 2007
• Activation of mGlu2/3 receptors as a new approach to treat schizophrenia: a randomized Phase 2 clinical trial
  Nature Medicine, 2007
• Cyclothiazide selectively inhibits mGluR1 receptors interacting with a common allosteric site for non-competitive antagonists
  Neuropharmacology, 2006
• Suppression of two major Fragile X Syndrome mouse model phenotypes by the mGluR5 antagonist MPEP
  Neuropharmacology, 2005